Elan Corporation, plc (ELN)
-NYSE 11.55 
0.05(0.43%) 1:33PM EDT - Nasdaq Real Time Price
| Prev Close: | 11.60 |
|---|
| Open: | 11.53 |
|---|
| Bid: | 11.54 x 1500 |
|---|
| Ask: | 11.55 x 6700 |
|---|
| 1y Target Est: | 12.25 |
|---|
| Beta: | 1.25 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 11.48 - 11.63 |
|---|
| 52wk Range: | 9.37 - 14.91 |
|---|
| Volume: | 4,608,528 |
|---|
| Avg Vol (3m): | 7,334,610 |
|---|
| Market Cap: | 6.89B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.07 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Royalty Pharma stands by reduced Elan bidat Reuters(Thu 8:42AM EDT)
- Royalty Pharma submits formal cash offer for Elan for $11.25 per sharetheflyonthewall.com(Thu 7:18AM EDT)
- InPlay: Elan: Royalty Pharma submits formal cash offer for Elan; offer price reflects $1 bln Dutch AuctionStrikePrice of $11.25 per Elan shareBriefing.com(Thu 7:09AM EDT)
- Royalty Pharma Submits Formal Cash Offer For Elan Corporation, plc ("Elan")PR Newswire(Thu 7:03AM EDT)
- ELAN CORP PLC FinancialsEDGAR Online Financials(Wed, May 1)
- 3 Stocks to Get on Your Watchlistat Motley Fool(Wed, May 1)
- Biotech Companies Breaking Upat Motley Fool(Fri, Apr 26)
- Biogen Earnings Strong, But Celgene Just So-SoInvestor's Business Daily(Thu, Apr 25)
- Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors’ RetirementBusiness Wire(Thu, Apr 25)
- Buybacks, Takeovers and a Potentially Lucrative Drugat Motley Fool(Wed, Apr 24)
- Elan Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, Apr 24)
- Elan tees up deals as sales of prized drug rise sharplyat Reuters(Wed, Apr 24)
- UPDATE 2-Elan tees up deals as sales of prized drug rise sharplyat Reuters(Wed, Apr 24)
- Elan Reports First Quarter 2013 Financial ResultsBusiness Wire(Wed, Apr 24)
- The Zacks Analyst Blog Highlights: Elan, Biogen Idec, WuXi PharmaTech, QLT and Reynolds AmericanZacks(Tue, Apr 23)
Key Statistics
| Forward P/E (1 yr): | 67.88 |
|---|
| P/S (ttm): | 34,608.60 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.04 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.01 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 133.64 |
|---|
Business Summary
Elan Corporation, plc operates as a biotechnology company in the United States, Ireland, and internationally. The company primarily develops ELND005, an orally bioavailable small molecule in Phase II clinical trial being investigated for multiple ...
View More